Darin Leigh Joins Metabolon as Chief Commercial Officer
06 juil. 2015 11h18 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., July 6, 2015 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announces that Darin Leigh has been appointed Chief Commercial Officer, a new...
Study Shows Quantose IR(TM) Measures Insulin Sensitivity Better Than A1C Test for Prediabetes
18 mars 2015 16h24 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., March 18, 2015 (GLOBE NEWSWIRE) -- Metabolon, Inc. announced results from a study using samples from the long-term ACT NOW diabetes prevention study of prediabetic...
Newly Published Results Support Clinical Validity of Quantose IGT(TM) Diabetes Test
20 janv. 2015 14h28 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 20, 2015 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announced that results from a study of its Quantose IGT™ test were recently...
Metabolon and Baylor College of Medicine Partner to Launch Global Metabolomic-Assisted Pathway Screen (MAPS) for Inborn Errors of Metabolism
03 sept. 2014 15h10 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C. and HOUSTON, Sept. 3, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc. and Baylor College of Medicine announced today that they have entered into a two-year, exclusive agreement...
Metabolon to Sponsor Study at Geisinger Medical Center With Quantose IR to Monitor Prediabetes Therapy
23 juin 2014 16h16 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., June 23, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc., a global leader in metabolomics, announced today that it will sponsor a pilot study to evaluate its Quantose IRTM test...